Here we assess the value of plasma amyloid-β1-42/1-40, phosphorylated-tau181 and glial fibrillary acidic protein to detect early Alzheimer’s disease pathology, accounting for confounding by genetic and early environmental factors. The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.